<html>
 <body>
  <text encoding="utf8" id="http://www.chfpatients.com/faq/dhf.htm" title="CHFpatients.com - Heart Failure FAQ - Diastolic Heart Failure">
   <h1 class="center">
    <span __boilernet_label="1">
     Diastolic Heart Failure
    </span>
   </h1>
   <div style="border:6px double #099; margin-right:20%; margin-left:20%">
    <p class="note" style="margin:7px 1% 7px 1%; text-align:center">
     <span __boilernet_label="1">
      The heart's pumping cycle has 2 phases
     </span>
     <b>
      <span __boilernet_label="1">
       :
      </span>
     </b>
     <br/>
     <span style="font:x-small Arial,sans-serif; line-height:50%">
     </span>
     <br/>
     <span style="background:transparent; color:#099; font:bold x-small Verdana,Arial,sans-serif">
      <span __boilernet_label="1">
       Diastole
      </span>
     </span>
     <br/>
     <span style="font-weight:normal">
      <span __boilernet_label="1">
       (pronounced
      </span>
      <b>
       <span __boilernet_label="1">
        :
       </span>
      </b>
      <span __boilernet_label="1">
       die ass tuh lee)
      </span>
     </span>
     <br/>
     <span __boilernet_label="1">
      the heart muscle relaxes and fills with blood
     </span>
     <br/>
     <span style="font:x-small Arial,sans-serif; line-height:50%">
     </span>
     <br/>
     <span style="background:transparent; color:#099; font:bold x-small Verdana,Arial,sans-serif">
      <span __boilernet_label="1">
       Systole
      </span>
     </span>
     <br/>
     <span style="font-weight:normal">
      <span __boilernet_label="1">
       (pronounced
      </span>
      <b>
       <span __boilernet_label="1">
        :
       </span>
      </b>
      <span __boilernet_label="1">
       sis tuh lee)
      </span>
     </span>
     <br/>
     <span __boilernet_label="1">
      the heart muscle contracts (squeezes) and pumps blood out into the body
     </span>
    </p>
   </div>
   <p>
    <br/>
    <span style="font:bold xx-small Verdana,Arial,sans-serif">
     <span __boilernet_label="1">
      updated July 5, 2006
     </span>
    </span>
    <span __boilernet_label="1">
     - People think of heart failure as a condition where the heart does not pump out enough blood. That is called systolic heart failure. However, many
    </span>
    <a href="http://www.chfpatients.com/glossary.htm#chfer" target="_blank">
     <span __boilernet_label="1">
      CHFers
     </span>
    </a>
    <span __boilernet_label="1">
     have a different kind of heart failure - caused when the heart does not fully relax, so it does not fill properly with blood. This is called diastolic heart failure. This page is about diastolic heart failure or DHF.
    </span>
    <br/>
    <span __boilernet_label="1">
     In mild DHF,
    </span>
    <a href="http://www.chfpatients.com/glossary_2.htm#sob" target="_blank">
     <span __boilernet_label="1">
      SOB
     </span>
    </a>
    <span __boilernet_label="1">
     and fatigue usually only happen during stress or activity. More severe DHF causes many of the same symptoms that systolic heart failure or SHF, causes.
    </span>
    <br/>
    <span __boilernet_label="1">
     A person with DHF has high pressures in the arteries of their lungs - pulmonary pressure. Their heart's pumping chambers may not be enlarged and their
    </span>
    <a href="http://www.chfpatients.com/faq/ef.htm" target="_blank">
     <span __boilernet_label="1">
      ejection fraction
     </span>
    </a>
    <span __boilernet_label="1">
     may be normal, but they still have the same nasty symptoms as a person with SHF.
    </span>
    <br/>
    <span class="h">
     <span __boilernet_label="1">
      In people with diastolic heart failure,
     </span>
     <a href="http://www.chfpatients.com/text/toprol-xl_versus_metoprolol.txt" target="_blank">
      <span __boilernet_label="1">
       Toprol-XL
      </span>
     </a>
     <span __boilernet_label="1">
      may be a better beta-blocker choice than Coreg. Too-low blood pressure can be a real problem for DHF patients. Toprol-XL does not lower blood pressure as much as Coreg.
     </span>
    </span>
   </p>
   <ul>
    <li>
     <a href="#causes">
      <span __boilernet_label="0" __num="26">
       What Causes DHF?
      </span>
     </a>
    </li>
    <li>
     <a href="#diagnosing">
      <span __boilernet_label="0" __num="27">
       Diagnosing DHF
      </span>
     </a>
    </li>
    <li>
     <a href="#prevalence">
      <span __boilernet_label="0" __num="28">
       How Common Is DHF?
      </span>
     </a>
    </li>
    <li>
     <a href="#mortality">
      <span __boilernet_label="0" __num="29">
       Mortality
      </span>
     </a>
    </li>
    <li>
     <a href="#complications">
      <span __boilernet_label="0" __num="30">
       Complications
      </span>
     </a>
    </li>
    <li>
     <a href="#treatment">
      <span __boilernet_label="0" __num="31">
       Treating Diastolic Heart Failure
      </span>
     </a>
     <ul>
      <li>
       <a href="#drug_general">
        <span __boilernet_label="0" __num="32">
         Drug Therapy - General Principles
        </span>
       </a>
      </li>
      <li>
       <a href="#nebivolol_for_seniors_with_good_EF">
        <span __boilernet_label="0" __num="33">
         New Drug Nebivolol Helps CHF Seniors with Normal EF
        </span>
       </a>
      </li>
      <li>
       <a href="#exercise">
        <span __boilernet_label="0" __num="34">
         Drugs and Exercise Tolerance
        </span>
       </a>
      </li>
      <li>
       <a href="#inotropes">
        <span __boilernet_label="0" __num="35">
         IV Drugs
        </span>
       </a>
      </li>
      <li>
       <a href="#digoxin">
        <span __boilernet_label="0" __num="36">
         Digoxin (Lanoxin, digitalis)
        </span>
       </a>
      </li>
      <li>
       <a href="#cad">
        <span __boilernet_label="0" __num="37">
         Coronary Artery Disease
        </span>
       </a>
      </li>
     </ul>
    </li>
    <li>
     <a href="#q_and_a">
      <span __boilernet_label="0" __num="38">
       Questions and Answers - The Discussion
      </span>
     </a>
    </li>
    <li>
     <a href="#source">
      <span __boilernet_label="0" __num="39">
       Source For This Page's Information
      </span>
     </a>
    </li>
    <li>
     <a href="http://www.chfpatients.com/text/faq_dhf_references.txt" target="_blank">
      <span __boilernet_label="0" __num="40">
       References
      </span>
     </a>
    </li>
   </ul>
   <h2>
    <span __boilernet_label="1">
     Causes of diastolic heart failure
    </span>
    <a name="causes">
    </a>
   </h2>
   <ul>
    <li>
     <a href="http://www.chfpatients.com/glossary_2.htm#ischemia" target="_blank">
      <span __boilernet_label="1">
       Ischemia
      </span>
     </a>
     <span __boilernet_label="1">
      - can be caused by
     </span>
     <a href="http://www.chfpatients.com/glossary.htm#cad" target="_blank">
      <span __boilernet_label="1">
       CAD
      </span>
     </a>
     <span __boilernet_label="1">
      or by a chronic too-fast heart rate. Ischemia prevents the heart muscle from fully relaxing and increases heart stiffness. Chronic ischemia results in
     </span>
     <a href="http://www.chfpatients.com/glossary_2.htm#remodeling" target="_blank">
      <span __boilernet_label="1">
       remodeling
      </span>
     </a>
     <span __boilernet_label="1">
      and DHF
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      pressure overload caused by chronic high blood pressure or aortic valve problems
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      infiltrative cardiomyopathies, also called restrictive cardiomyopathy
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      pericarditis - inflammation of the sac around the outside of the heart
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      normal aging can cause some DHF
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      chemotherapy for diseases like cancer
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      genetic causes
     </span>
    </li>
   </ul>
   <h3>
    <span __boilernet_label="1">
     Diagnosing diastolic heart failure
    </span>
    <a name="diagnosing">
    </a>
   </h3>
   <p>
    <span __boilernet_label="1">
     How to always diagnose DHF accurately is uncertain but a correct diagnosis
    </span>
    <i>
     <span __boilernet_label="1">
      is
     </span>
    </i>
    <span __boilernet_label="1">
     important. Some guidelines propose that 3 requirements be met to make the call
    </span>
    <b>
     <span __boilernet_label="1">
      :
     </span>
    </b>
   </p>
   <ol>
    <li>
     <span __boilernet_label="1">
      symptoms or signs of
     </span>
     <a href="http://www.chfpatients.com/CHFinfo.htm" target="_blank">
      <span __boilernet_label="1">
       CHF
      </span>
     </a>
    </li>
    <li>
     <span __boilernet_label="1">
      normal systolic function
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      abnormal diastolic function
     </span>
    </li>
   </ol>
   <p>
    <span __boilernet_label="1">
     There are some situations where symptoms alone may lead to a
    </span>
    <i>
     <span __boilernet_label="1">
      mis
     </span>
    </i>
    <span __boilernet_label="1">
     diagnosis. This is especially true in older patients who get short of breath mainly because they have very poor physical fitness. It can also happen with non-heart-related shortness of breath such as with lung disease. So diagnosing DHF requires some signs or symptoms of CHF like lung congestion, edema, raised jugular vein, etc. You do have to rule out problems like mitral valve disease and and lung disease.
    </span>
    <br/>
    <span __boilernet_label="1">
     DHF cannot usually be distinguished from
    </span>
    <a href="http://www.chfpatients.com/glossary_2.htm#shf" target="_blank">
     <span __boilernet_label="1">
      SHF
     </span>
    </a>
    <span __boilernet_label="1">
     by patient history, physical exam, x-ray, and EKG alone. Diagnosis
    </span>
    <i>
     <span __boilernet_label="1">
      requires
     </span>
    </i>
    <span __boilernet_label="1">
     an estimate of LV size and
    </span>
    <a href="http://www.chfpatients.com/faq/ef.htm" target="_blank">
     <span __boilernet_label="1">
      EF
     </span>
    </a>
    <span __boilernet_label="1">
     . These measurements can be made using
    </span>
    <a href="http://www.chfpatients.com/tests/tests.htm" target="_blank">
     <span __boilernet_label="1">
      echo, MUGA, or cath
     </span>
    </a>
    <span __boilernet_label="1">
     . Really, DHF diagnosis is a matter of ruling out other possible causes in patients seeming to have heart failure but who have normal heart size and EF.
    </span>
    <br/>
    <span __boilernet_label="1">
     Since echo does have limits for spotting DHF and cath is invasive, one trial studied whether the BNP blood test could help spot diastolic heart failure. That study is shown on the
    </span>
    <a href="http://www.chfpatients.com/tests/bnp.htm" target="_blank">
     <span __boilernet_label="1">
      BNP Test page
     </span>
    </a>
    <span __boilernet_label="1">
     .
    </span>
    <span class="h">
     <span __boilernet_label="1">
      It turns out that a quick BNP test can help a doctor diagnose DHF.
     </span>
    </span>
   </p>
   <div class="center" style="margin:35px 0px 20px 0px">
    <table border="1" cellpadding="3" cellspacing="1" class="table2" frame="hsides" rules="all">
     <tbody>
      <tr>
       <td class="highlight" colspan="3" style="text-align:center">
        <span __boilernet_label="1">
         Diagnosis
        </span>
        <b>
         <span __boilernet_label="1">
          :
         </span>
        </b>
        <span __boilernet_label="1">
         Systolic versus diastolic heart failure
        </span>
       </td>
      </tr>
      <tr class="tr">
       <td>
       </td>
       <td align="center">
        <span __boilernet_label="0" __num="82">
         Systolic Heart Failure - Reduced EF
        </span>
        <br/>
        <span __boilernet_label="0" __num="83">
         30 patients
        </span>
       </td>
       <td align="center">
        <span __boilernet_label="0" __num="84">
         Diastolic Heart Failure - Normal EF
        </span>
        <br/>
        <span __boilernet_label="0" __num="85">
         20 patients
        </span>
       </td>
      </tr>
      <tr>
       <td class="highlight" colspan="3">
        <span __boilernet_label="1">
         Symptoms
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Shortness of breath on exertion
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         85%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         96%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Waking at night short of breath
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         55%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         50%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Difficulty breathing except upright
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         60%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         73%
        </span>
       </td>
      </tr>
      <tr>
       <td class="highlight" colspan="3">
        <span __boilernet_label="1">
         Physical Examination
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Jugular vein swollen
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         35%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         46%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Sounds in lungs
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         72%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         70%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <a href="http://www.fpnotebook.com/CV72.htm" target="_blank">
         <span __boilernet_label="1">
          Point of maximum impulse
         </span>
        </a>
       </td>
       <td>
        <span __boilernet_label="1">
         50%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         60%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <a href="s3s4.htm" target="_blank">
         <span __boilernet_label="0" __num="106">
          S3
         </span>
        </a>
       </td>
       <td>
        <span __boilernet_label="0" __num="107">
         45%
        </span>
       </td>
       <td>
        <span __boilernet_label="0" __num="108">
         65%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <a href="s3s4.htm" target="_blank">
         <span __boilernet_label="0" __num="109">
          S4
         </span>
        </a>
       </td>
       <td>
        <span __boilernet_label="0" __num="110">
         45%
        </span>
       </td>
       <td>
        <span __boilernet_label="0" __num="111">
         66%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Enlarged (congested) liver
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         15%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         16%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <a href="edema.htm" target="_blank">
         <span __boilernet_label="1">
          Edema
         </span>
        </a>
       </td>
       <td>
        <span __boilernet_label="1">
         30%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         40%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Heart enlargement on chest x-ray
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         90%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         96%
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         High pulmonary (lung) pressures
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         75%
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         80%
        </span>
       </td>
      </tr>
     </tbody>
    </table>
   </div>
   <h4>
    <span __boilernet_label="1">
     How common is DHF?
    </span>
    <a name="prevalence">
    </a>
   </h4>
   <p>
    <span __boilernet_label="1">
     As many as 33% of patients with obvious heart failure and a normal EF may have DHF. Risk of DHF increases with age
    </span>
    <b>
     <span __boilernet_label="1">
      :
     </span>
    </b>
   </p>
   <ol>
    <li>
     <span __boilernet_label="1">
      15% in patients under 60 years
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      35% in patients 60 to 70 years
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      50% in patients over 70 years old
     </span>
    </li>
   </ol>
   <h5>
    <span __boilernet_label="1">
     Mortality
    </span>
    <a name="mortality">
    </a>
   </h5>
   <p>
    <span class="h">
     <span __boilernet_label="1">
      Prognosis of patients with DHF is better than for SHF.
     </span>
    </span>
    <span __boilernet_label="1">
     Annual mortality for DHF is about 5 to 8%, while it is about 10 to 15% for SHF. In healthy people of the same age, mortality is about 1%. In DHF patients, prognosis is also affected by cause. When CAD is
    </span>
    <i>
     <span __boilernet_label="1">
      not
     </span>
    </i>
    <span __boilernet_label="1">
     the cause, annual mortality is much better, at about 2% to 3%. Age also affects risk of death. The 5-year mortality rate in DHF patients is
    </span>
    <b>
     <span __boilernet_label="1">
      :
     </span>
    </b>
   </p>
   <ol>
    <li>
     <span __boilernet_label="1">
      25% in patients under 60 years old
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      35% in patients 60 to 70 years
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      50% in patients over 70 years old
     </span>
    </li>
   </ol>
   <h6>
    <span __boilernet_label="1">
     Complications
    </span>
    <a name="complications">
    </a>
   </h6>
   <p>
    <span __boilernet_label="1">
     The complication rate is about the same as for SHF patients. DHF causes frequent outpatient visits and hospital admissions. The one year readmission rate is almost 50% in DHF patients.
    </span>
   </p>
   <div style="background:transparent; color:#f00; font:italic bold medium Verdana,Arial,sans-serif; letter-spacing:.07em">
    <span __boilernet_label="1">
     Treatment
    </span>
    <a name="treatment">
    </a>
   </div>
   <p>
    <a href="guidelines_99.htm" target="_blank">
     <span __boilernet_label="1">
      Treatment guidelines
     </span>
    </a>
    <span __boilernet_label="1">
     for systolic heart failure are based on large, properly done trials. Unfortunately, no such trials exist for DHF. So guidelines come from small trials, a doctor's experience, and his understanding of the disease. The
    </span>
    <i>
     <span __boilernet_label="1">
      general
     </span>
    </i>
    <span __boilernet_label="1">
     approach to treating DHF has 3 main steps
    </span>
    <b>
     <span __boilernet_label="1">
      :
     </span>
    </b>
   </p>
   <ol>
    <li>
     <span __boilernet_label="1">
      Treatment should reduce symptoms, mainly by lowering
     </span>
     <a href="http://www.chfpatients.com/glossary_2.htm#pulmonary" target="_blank">
      <span __boilernet_label="1">
       pulmonary
      </span>
     </a>
     <span __boilernet_label="1">
      pressure. Ways to reduce pressure include reducing heart size, maintaining good pumping in the heart's upper chambers, and slowing the heart rate.
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      Treatment should target the underlying cause if possible. For example, high blood pressure should be controlled,
     </span>
     <a href="http://www.chfpatients.com/glossary_2.htm#remodeling" target="_blank">
      <span __boilernet_label="1">
       remodeling
      </span>
     </a>
     <span __boilernet_label="1">
      should be reversed, the aortic valve replaced if necessary, and ischemia treated by increasing blood flow to the heart and reducing its need for oxygen
     </span>
    </li>
    <li>
     <span __boilernet_label="1">
      Treatment should target the bodily systems changed by the disease, mainly
     </span>
     <a href="http://www.chfpatients.com/glossary_2.htm#neurohormones" target="_blank">
      <span __boilernet_label="1">
       neurohormonal
      </span>
     </a>
     <span __boilernet_label="1">
      systems
     </span>
    </li>
   </ol>
   <div class="subheading">
    <span __boilernet_label="1">
     Drug Therapy - General Principles
    </span>
    <a name="drug_general">
    </a>
   </div>
   <p>
    <span class="h">
     <span __boilernet_label="1">
      With some exceptions, many of the drugs used to treat systolic heart pressure are also used to treat diastolic heart failure. However, the reason they are used and the dose may be different for DHF
     </span>
    </span>
    <span __boilernet_label="1">
     .
    </span>
    <br/>
    <span __boilernet_label="1">
     For example, in DHF beta-blockers are used to make filling the heart with blood take longer, and to change the heart's response to exercise. In SHF, beta-blockers are used to increase pumping power and reverse heart remodeling. Diuretic dose for DHF is usually much smaller than for SHF. Calcium channel blockers have no place in SHF treatment but may help DHF.
    </span>
    <br/>
    <span __boilernet_label="1">
     The first step in treating DHF patients is to reduce lung congestion. You do that by lowering pulmonary (lung) pressure. This has 3 steps
    </span>
    <b>
     <span __boilernet_label="1">
      :
     </span>
    </b>
   </p>
   <dl>
    <dt class="arial">
     <span __boilernet_label="1">
      Reduce heart size
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      At first, heart size
     </span>
     <span __boilernet_label="1">
      can be reduced by restricting fluid and sodium intake, by dialysis or filtering the blood,
     </span>
     <a href="http://www.chfpatients.com/glossary_2.htm#plasmapheresis" target="_blank">
      <span __boilernet_label="1">
       plasmapheresis
      </span>
     </a>
     <span __boilernet_label="1">
      , and diuretics. Relaxing (dilating) the blood vessels using nitro or morphine is effective but should be started at low doses to avoid low blood pressure. Low blood pressure can be a real problem in DHF patients.
     </span>
     <i>
      <span __boilernet_label="1">
       Long-term
      </span>
     </i>
     <span __boilernet_label="1">
      treatment should include small to moderate diuretic doses, mild doses of long-acting nitro, and
     </span>
     <a href="http://www.chfpatients.com/rec/recipes.htm" target="_blank">
      <span __boilernet_label="1">
       restricted sodium intake
      </span>
     </a>
     <span __boilernet_label="1">
      .
     </span>
     <a href="http://www.chfpatients.com/meds.htm#aldactone2" target="blank">
      <span __boilernet_label="1">
       Aldactone
      </span>
     </a>
     <span __boilernet_label="1">
      (spironolactone) may be effective long-term because it suppresses the
     </span>
     <a href="http://www.chfpatients.com/glossary_2.htm#ras" target="_blank">
      <span __boilernet_label="1">
       RAS
      </span>
     </a>
     <span __boilernet_label="1">
      . ACE inhibitors and
     </span>
     <a href="http://www.chfpatients.com/glossary.htm#arb" target="_blank">
      <span __boilernet_label="1">
       ARBs
      </span>
     </a>
     <span __boilernet_label="1">
      reduce fluid retention and oxygen demand.
     </span>
     <br/>
    </dd>
    <dt class="arial">
     <span __boilernet_label="1">
      Make the heart's chambers beat together as a team
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      The second step in lowering pulmonary pressure is to keep the heart's upper chambers (atriums) beating properly.
     </span>
     <span class="h">
      <span __boilernet_label="1">
       Atrial fibrillation is poorly tolerated in DHF patients because it increases diastolic pressures, causing lung congestion and low blood pressure.In patients with a-fib, restoring normal rhythm should be a priority.
      </span>
     </span>
     <span __boilernet_label="1">
      Patients who need a
     </span>
     <a href="http://www.chfpatients.com/implants/implants.htm" target="_blank">
      <span __boilernet_label="1">
       pacemaker
      </span>
     </a>
     <span __boilernet_label="1">
      should have atrial pacing as well as ventricular pacing.
     </span>
     <br/>
    </dd>
    <dt class="arial">
     <span __boilernet_label="1">
      Slowing the heart rate
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      The third step in lowering pulmonary pressures is to slow the heart rate. This gives the heart more time to relax so it can fill with blood.
     </span>
     <span class="h">
      <span __boilernet_label="1">
       Fast heart rate is poorly tolerated in DHF patients
      </span>
     </span>
     <span __boilernet_label="1">
      because rapid heart rate
     </span>
     <b>
      <span __boilernet_label="1">
       :
      </span>
     </b>
     <ol style="margin:4px 3% 0px 5%">
      <li>
       <span __boilernet_label="1">
        increases the heart's oxygen demand and reduces blood flow to the heart, causing
       </span>
       <a href="http://www.chfpatients.com/glossary_2.htm#ischemia" target="_blank">
        <span __boilernet_label="1">
         ischemia
        </span>
       </a>
       <span __boilernet_label="1">
        even without
       </span>
       <a href="http://www.chfpatients.com/glossary.htm#cad" target="_blank">
        <span __boilernet_label="1">
         CAD
        </span>
       </a>
      </li>
      <li>
       <span __boilernet_label="1">
        prevents full relaxation of the heart muscle, which raises pressure and reduces the heart's flexibility
       </span>
      </li>
      <li>
       <span __boilernet_label="1">
        shortens the heart's relaxation period, making it incomplete, which reduces the amount of blood pumped per beat
       </span>
      </li>
     </ol>
    </dd>
   </dl>
   <p style="margin-top:7px">
    <span __boilernet_label="1">
     For these reasons, most doctors use beta-blockers and calcium channel blockers to slow the heart rate a
    </span>
    <i>
     <span __boilernet_label="1">
      lot
     </span>
    </i>
    <span __boilernet_label="1">
     in DHF patients. However, slowing the heart rate too much can reduce cardiac output despite better filling.
    </span>
    <span class="h">
     <span __boilernet_label="1">
      This is why DHF patients need very individualized treatment.
     </span>
    </span>
    <span __boilernet_label="1">
     An initial goal might be a resting heart rate of about 60 beats per minute.
    </span>
    <br/>
    <span __boilernet_label="1">
     Beta-blockers and calcium channel blockers increase the time it takes the heart to fill with blood. This helps keep pulmonary pressures low. However, these drugs also directly
    </span>
    <i>
     <span __boilernet_label="1">
      reduce
     </span>
    </i>
    <span __boilernet_label="1">
     the heart's ability to relax by their effects at the cell level. It's a tricky balance to strike in DHF patients. The overall effect of these drugs in DHF patients is improved symptoms.
    </span>
    <br/>
    <span class="h">
     <span __boilernet_label="1">
      The long-term effect of calcium channel blockers on diastolic heart failure patients is unknown. All calcium channel blockers except
     </span>
    </span>
    <a href="http://www.chfpatients.com/meds.htm#amlodipine2" target="_blank">
     <span class="h" style="font-weight:bold">
      <span __boilernet_label="1">
       amlodipine
      </span>
     </span>
    </a>
    <span class="h">
     <i>
      <span __boilernet_label="1">
       increase
      </span>
     </i>
     <span __boilernet_label="1">
      mortality in patients with
     </span>
     <i>
      <span __boilernet_label="1">
       systolic
      </span>
     </i>
     <span __boilernet_label="1">
      heart failure.
     </span>
    </span>
   </p>
   <div class="subheading">
    <a name="nebivolol_for_seniors_with_good_EF">
    </a>
    <span __boilernet_label="1">
     Nebivolol Helps CHF Seniors with Normal EF
    </span>
   </div>
   <p>
    <i>
     <span __boilernet_label="1">
      March 27, 2006
     </span>
    </i>
    <span __boilernet_label="1">
     - A "third generation" (new) beta-blocker called Nebivolol is on the way.
    </span>
    <span class="h">
     <span __boilernet_label="1">
      Nebivolol has the main good benefit of Toprol-XL (beta-1 blocking without beta-2 blocking) plus one of the good benefits of Coreg (relaxing the arteries, called vasodilation). It also helps
     </span>
    </span>
    <a href="http://www.chfpatients.com/glossary.htm#endothelium" target="_blank">
     <span class="h">
      <span __boilernet_label="1">
       endothelial
      </span>
     </span>
    </a>
    <span class="h">
     <span __boilernet_label="1">
      function and is a powerful anti-oxidant. Nebivolol does this without all of Coreg's side effects.
     </span>
    </span>
    <br/>
    <span __boilernet_label="1">
     Researchers studied how nebivolol affects systolic versus diastolic left heart function in patients. This substudy included 104 patients
    </span>
    <b>
     <span __boilernet_label="1">
      ;
     </span>
    </b>
    <span __boilernet_label="1">
     43 had an EF less than 36%. Echo was done on each patient to take quite a few heart measures
    </span>
    <span __boilernet_label="1">
     at study start and again one year later.
    </span>
    <br/>
    <span __boilernet_label="1">
     In the group with EF less than 36%, nebivolol reduced heart size
    </span>
    <span __boilernet_label="1">
     and improved EF 5%
    </span>
    <span __boilernet_label="1">
     . Other measures remained the same. In patients with EF higher than 36%, no changes in the heart muscle were seen.
    </span>
    <br/>
    <span class="h">
     <span __boilernet_label="1">
      So in patients with weakly pumping hearts (low EF), nebivolol reduces heart size and improves EF. In patients with near-normal or normal EF (diastolic heart failure) no changes in the heart muscle were seen. None the less, risk of death or heart-related hospitalization improved in both groups in SENIORS.
     </span>
    </span>
    <br/>
    <span __boilernet_label="1">
     The SENIORS trial showed that nebivolol reduces risk of death and heart-related hospitalizations in senior CHFers
    </span>
    <b>
     <span __boilernet_label="1">
      regardless of EF
     </span>
    </b>
    <span __boilernet_label="1">
     . What does this mean? It suggests that
    </span>
    <a href="http://www.chfpatients.com/glossary.htm#chfer" target="_blank">
     <span __boilernet_label="1">
      CHFers
     </span>
    </a>
    <span __boilernet_label="1">
     with
    </span>
    <a href="http://www.chfpatients.com/faq/dhf.htm" target="_blank">
     <span __boilernet_label="1">
      diastolic heart failure
     </span>
    </a>
    <span __boilernet_label="1">
     may now have a drug proven to help them.
    </span>
    <br/>
    <i>
     <span __boilernet_label="1">
      Jon's note
     </span>
    </i>
    <span __boilernet_label="1">
     : The average age in the SENIORS trial was 76 years.
    </span>
    <br/>
    <br/>
    <span __boilernet_label="1">
     Source: Eur Heart J. 2006 Mar;27(5):562-8. Epub 2006 Jan 27.
    </span>
    <br/>
    <span __boilernet_label="1">
     Title: Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
    </span>
    <br/>
    <span __boilernet_label="1">
     Authors: Ghio S , Magrini G , Serio A, Klersy C, Fucilli A, Ronaszeki A, Karpati P, Mordenti G, Capriati A, Poole-Wilson PA, Tavazzi L; SENIORS investigators.
    </span>
    <span __boilernet_label="1">
     PMID: 16443607
    </span>
   </p>
   <div class="subheading">
    <span __boilernet_label="1">
     Drugs and Exercise Tolerance
    </span>
    <a name="exercise">
    </a>
   </div>
   <p>
    <span __boilernet_label="1">
     Exercise in a healthy person makes the heart relax more quickly and lowers LV pressure faster. The heart muscle actually stretches and gets larger when full of blood just before pumping it out. This increases
    </span>
    <a href="http://www.chfpatients.com/faq/ef.htm" target="_blank">
     <span __boilernet_label="1">
      EF
     </span>
    </a>
    <span __boilernet_label="1">
     . In a healthy person, these actions help the body handle exercise.
    </span>
    <br/>
    <span __boilernet_label="1">
     In DHF, those actions are very limited. The heart's stiffness prevents it from stretching to increase its size when filled with blood. EF does not rise, and patients get short of breath and very tired. Often, there is quite a rise in blood pressure and heart rate during exercise. The rise in blood pressure makes the heart work harder, which screws up the entire pumping cycle.
    </span>
    <br/>
    <span __boilernet_label="1">
     These changes increase diastolic pressures. High diastolic pressures reduce lung function and make breathing harder. Low heart output during exercise causes fatigue in the legs and other muscles.
    </span>
    <br/>
    <span class="h">
     <span __boilernet_label="1">
      Small trials show that calcium channel blockers, beta-blockers, and
     </span>
    </span>
    <a href="http://www.chfpatients.com/ace.htm#arb" target="_blank">
     <span class="h">
      <span __boilernet_label="1">
       ARBs
      </span>
     </span>
    </a>
    <span class="h">
     <span __boilernet_label="1">
      improve exercise ability in many DHF patients. However, these drugs do not always improve heart function
     </span>
     <span __boilernet_label="1">
      .
     </span>
    </span>
   </p>
   <div class="subheading">
    <span __boilernet_label="1">
     Inotropes
    </span>
    <a name="inotropes">
    </a>
   </div>
   <p>
    <span __boilernet_label="1">
     Use
    </span>
    <a href="http://www.chfpatients.com/inotropes.htm" target="_blank">
     <span __boilernet_label="1">
      inotropic drugs
     </span>
    </a>
    <span __boilernet_label="1">
     with caution. Since ejection fraction is often okay in DHF patients, inotropes may give no benefit at all. However, such drugs can cause harm in these patients. Inotropic drugs may help in the short-term for lung congestion
    </span>
    <span __boilernet_label="1">
     but even short-term use may cause
    </span>
    <a href="http://www.chfpatients.com/glossary_2.htm#ischemia" target="_blank">
     <span __boilernet_label="1">
      ischemia
     </span>
    </a>
    <span __boilernet_label="1">
     , speed up heart rate, or trigger arrhythmias.
    </span>
   </p>
   <div class="subheading">
    <span __boilernet_label="1">
     Digoxin (Lanoxin, digitalis)
    </span>
    <a name="digoxin">
    </a>
   </div>
   <p>
    <a href="http://www.chfpatients.com/meds_old.htm#digoxin" target="blank">
     <span __boilernet_label="1">
      Digoxin
     </span>
    </a>
    <span __boilernet_label="1">
     (Lanoxin)
    </span>
    <span __boilernet_label="1">
     strengthens the heart's pumping power. This increases
    </span>
    <span __boilernet_label="1">
     energy demand
    </span>
    <span __boilernet_label="1">
     , which may only show up during stress like exercise or ischemia, when digoxin can worsen diastolic function.
    </span>
    <span class="h">
     <span __boilernet_label="1">
      With the exception of patients in chronic atrial fibrillation (to slow ventricular rate), digoxin is not recommended for DHF.
     </span>
    </span>
   </p>
   <div class="subheading">
    <span __boilernet_label="1">
     Coronary Artery Disease
    </span>
    <a name="cad">
    </a>
   </div>
   <p>
    <span __boilernet_label="1">
     In
    </span>
    <a href="http://www.chfpatients.com/glossary.htm#cad" target="_blank">
     <span __boilernet_label="1">
      CAD
     </span>
    </a>
    <span __boilernet_label="1">
     , treatment should aim to reduce the heart's oxygen demand and increase blood flow to the heart. Drugs like nitrates (nitroglycerine), calcium channel blockers, and beta-blockers have all been shown to help. Clearing blocked arteries with angioplasty or
    </span>
    <a href="http://www.chfpatients.com/glossary.htm#cabg" target="_blank">
     <span __boilernet_label="1">
      CABG
     </span>
    </a>
    <span __boilernet_label="1">
     may also help diastolic heart failure patients with CAD.
    </span>
   </p>
   <div class="center" style="margin:20px 9% 20px 6%">
    <table border="1" cellpadding="3" cellspacing="1" class="table" frame="hsides" rules="all">
     <tbody>
      <tr>
       <td class="highlight" colspan="2" style="text-align:center; font-family:Verdana,Arial,sans-serif">
        <span __boilernet_label="1">
         Drug treatment of diastolic heart failure
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Loop diuretics
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         Bumex (bumetanide), Lasix (furosemide), Demadex (torsemide)
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Thiazide diuretics
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         Hygroton (chlorthalidone), Hydrodiuril, Esidrix (HCTZ, hydrochlorothiazide), Amiloride,
        </span>
        <a href="http://www.chfpatients.com/meds.htm#aldactone2" target="blank">
         <span __boilernet_label="1">
          Aldactone
         </span>
        </a>
        <span __boilernet_label="1">
         (spironolactone)
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Long-acting nitrates
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         Isordil, Sorbitrate (Isosorbide Dinitrate), Imdur (Isosorbide mononitrate)
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Beta-blockers
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         See
        </span>
        <a href="http://www.chfpatients.com/beta_overview.htm" target="_blank">
         <span __boilernet_label="1">
          this page
         </span>
        </a>
       </td>
      </tr>
      <tr>
       <td>
        <span __boilernet_label="1">
         Calcium channel blockers
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         Norvasc (amlodipine), Cardizem (diltiazem), Isoptin (verapamil), Procardia (nifedipine)
        </span>
       </td>
      </tr>
      <tr>
       <td>
        <a href="http://www.chfpatients.com/glossary_2.htm#ras" target="_blank">
         <span __boilernet_label="1">
          RAS
         </span>
        </a>
        <span __boilernet_label="1">
         inhibitors
        </span>
       </td>
       <td>
        <span __boilernet_label="1">
         ACE inhibitors (see
        </span>
        <a href="http://www.chfpatients.com/ace.htm" target="_blank">
         <span __boilernet_label="1">
          this page
         </span>
        </a>
        <span __boilernet_label="1">
         ), ARBs (see
        </span>
        <a href="http://www.chfpatients.com/ace.htm#arb" target="_blank">
         <span __boilernet_label="1">
          this page
         </span>
        </a>
        <span __boilernet_label="1">
         ), and aldosterone antagonists
        </span>
       </td>
      </tr>
     </tbody>
    </table>
   </div>
   <div class="heading">
    <span __boilernet_label="1">
     Questions and Answers
    </span>
    <a name="q_and_a">
    </a>
   </div>
   <dl>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Is the rise in DHF cases caused by doctors better recognizing the condition or has there been an actual increase in the number of cases?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      I think it is both. We are recognizing it better. Also, the general population is aging so high blood pressure, heart disease, and diabetes are rising just because they are more common in the elderly. Age itself causes changes in the heart that encourage DHF
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Why the controversy surrounding the diagnosis of DHF?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      The guidelines that exist or have been proposed come from the European Cardiology Society and the Canadian Heart Society, as well as from a recent editorial by Vasan and Levy published in the journal Circulation. They all require that 3 standards be met to diagnose DHF
     </span>
     <b>
      <span __boilernet_label="1">
       :
      </span>
     </b>
     <br/>
     <br/>
     <b>
      <span __boilernet_label="0" __num="296">
       1)
      </span>
     </b>
     <span __boilernet_label="1">
      signs and symptoms of heart failure
     </span>
     <br/>
     <b>
      <span __boilernet_label="0" __num="298">
       2)
      </span>
     </b>
     <span __boilernet_label="1">
      normal EF
     </span>
     <br/>
     <b>
      <span __boilernet_label="0" __num="300">
       3)
      </span>
     </b>
     <span __boilernet_label="1">
      problems with diastolic function seen by
     </span>
     <a href="http://www.chfpatients.com/tests/tests.htm" target="_blank">
      <span __boilernet_label="1">
       cath or echo
      </span>
     </a>
     <br/>
     <br/>
     <span __boilernet_label="1">
      I think these criteria are too tight and that number 3 should be eliminated. Ninety percent of patients who fit the first 2 will indeed turn out to have diastolic heart failure confirmed by cath. The problem arises because measuring diastolic function with noninvasive tests like echo is difficult and confusing.
     </span>
     <br/>
     <span __boilernet_label="1">
      Why? Echo usually measures what we call the E and A velocities. However, E-wave velocity drops with age, heart enlargement, and DHF. So in someone with congested lungs and signs of high heart pressures
     </span>
     <span __boilernet_label="1">
      those E-waves can appear normal. While the E-wave should be low in DHF patients, it may appear normal if the doctor is not experienced at treating diastolic heart failure.
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Is finding diastolic problems on an echo that is done for another reason important, even in a patient with no history or symptoms of
     </span>
     <a href="http://www.chfpatients.com/CHF.htm" target="_blank">
      <span __boilernet_label="1">
       CHF
      </span>
     </a>
     <span __boilernet_label="1">
      ?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Yes. In systolic heart failure, a wide range of patient types is seen - from those with low EFs but no symptoms, to those with mild or moderate symptoms, to
     </span>
     <a href="http://www.chfpatients.com/CHFinfo.htm#classes" target="_blank">
      <span __boilernet_label="1">
       class 4
      </span>
     </a>
     <span __boilernet_label="1">
      patients with severe symptoms even at rest. The same range is likely to be seen in diastolic heart failure patients
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Since most of the blood that fills the LV does so in the early part of the filling phase, why does it help to lengthen that phase in DHF patients by slowing heart rate? Doesn't increasing heart rate increase cardiac output?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      While speeding up heart rate increases output, it also raises pressure
     </span>
     <span __boilernet_label="1">
      , making symptoms worse. In a healthy person, raising heart rate does not change pressures
     </span>
     <span __boilernet_label="1">
      much because the ventricle is able to relax faster as heart rate speeds up.
     </span>
     <br/>
     <span __boilernet_label="1">
      However, in DHF patients, the response to increased heart rate is not normal. When heart rate speeds up, the ventricle cannot relax any faster. This raises pressures
     </span>
     <span __boilernet_label="1">
      . By slowing heart rate, you give the ventricle more time to relax, lowering filling pressures. Also, many DHF patients have ischemia. By slowing the heart rate, you reduce the heart's need for oxygen and that helps balance supply and demand of blood and oxygen
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Seeing that pretty much the same drugs are used to treat both diastolic are systolic heart failure, how important is it to tell DHF from SHF?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      There are at least 40 well-done trials to guide treatment for systolic heart failure patients. This is not true for DHF, so its treatment is less certain.
     </span>
     <span class="h">
      <span __boilernet_label="1">
       Even though we say ACE inhibitors will probably help and ARBs may help, and beta-blockers may help, and so on, it is not proven in large numbers of DHF patients.
      </span>
     </span>
     <span __boilernet_label="1">
      Also, there are differences in the way you use those drugs and in the doses you use.
     </span>
     <br/>
     <span __boilernet_label="1">
      The best example is beta-blockers. Treating heart failure in patients with an EF of 30% requires that beta-blocker dose be raised carefully, starting with tiny doses and raising it slowly over several months. In the DHF patient, that very slow rise in dose is not usually necessary.
     </span>
     <br/>
     <span __boilernet_label="1">
      Another example is calcium channel blockers. These drugs should not be used in systolic heart failure patients at all, but they may help DHF patients. As another example, diuretic use needs to be much more cautious in the DHF patient since drying them out too much can easily cause too-low blood pressure.
     </span>
     <br/>
     <span __boilernet_label="1">
      So even though the same drugs may be used to treat SHF and DHF, there are important differences. It is important for doctors to be aware of the differences when treating CHF patients
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Have beta-blockers and calcium channel blockers been shown to reverse measurements of diastolic dysfunction?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span class="h">
      <span __boilernet_label="1">
       If you give beta-blockers to DHF patients, their relaxation rate gets worse instead of better. Despite this, patients feel better -
      </span>
     </span>
     <span class="highlight">
      <span __boilernet_label="1">
       so measurements don't always agree with how patients actually do while taking a drug.
      </span>
     </span>
     <span class="h">
      <span __boilernet_label="1">
       With calcium channel blockers, DHF patients feel better while taking them
      </span>
      <i>
       <span __boilernet_label="1">
        and
       </span>
      </i>
      <span __boilernet_label="1">
       their filling rates usually get better. There is a complex relationship between how any one drug affects a person versus how that drug affects the measurements we take of that person's heart function.
      </span>
     </span>
     <br/>
     <span __boilernet_label="1">
      One study that used a calcium channel blocker and another study using an ARB showed improved exercise times in patients taking these drugs. However, neither study showed improved measurements of heart relaxation or stiffness. I don't think you can rely just on measures of heart function to guide treatment.
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      In making a DHF diagnosis, what must be ruled out besides systolic heart failure?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Besides excluding SHF, it is also important to rule out mitral valve stenosis and chronic lung disease, both of which can imitate heart failure with a normal EF
     </span>
     <br/>
     <br/>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Question
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      What blood pressure drugs are most likely to help heart enlargement in DHF patients?
     </span>
    </dd>
    <dt>
     <span __boilernet_label="1">
      Dr. Zile
     </span>
    </dt>
    <dd>
     <span __boilernet_label="1">
      Although it hasn't been clearly proven yet, I think drugs that alter the neurohormonal systems work well. They not only lower pressure, but they also reduce the effects of overactive bodily systems. The problem is that in most trials, heart enlargement only goes down about 10 to 15%. This will probably improve heart function but not totally reverse DHF. If those high blood pressure trials had been longer by 5 or 10 years, we might have seen more improvement proven down the road.
     </span>
     <br/>
     <span __boilernet_label="1">
      What evidence do I have to support that? The answer comes from patients with aortic stenosis who had their aortic valves replaced. Three to 5 years after aortic valve replacement, ventricular size and stiffness often returned to normal, improving the heart's stiffness and relaxation
     </span>
     <a name="source">
     </a>
    </dd>
   </dl>
   <p>
    <span __boilernet_label="1">
     Title: Diastolic Heart Failure: Diagnosis and Treatment
    </span>
    <br/>
    <span __boilernet_label="1">
     Authors: Dr. Michael R. Zile, Dr. Janet M. Simsic
    </span>
    <br/>
    <span __boilernet_label="1">
     Source: Clinical Cornerstone 3(2):13-24, 2000
    </span>
   </p>
   <p class="smallcounter">
    <span __boilernet_label="0" __num="352">
     All information on this site is opinion only. All concepts, explanations, trials, and studies have been re-written in plain English and may contain errors. I am not a doctor. Use the reference information at the end of each article to search
    </span>
    <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi" target="_blank">
     <span __boilernet_label="0" __num="353">
      MedLine
     </span>
    </a>
    <span __boilernet_label="0" __num="354">
     for more complete and accurate information. All original copyrights apply. No information on this page should be used by any person to affect their medical, legal, educational, social, or psychological treatment in any way. I am not a doctor. This web site and all its pages, graphics, and content copyright © 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006 Jon C.
    </span>
   </p>
   <div class="center" style="padding-top:30px">
    <table border="0" cellpadding="0" cellspacing="0" width="96%">
     <tbody>
      <tr>
       <td align="center" class="counter" valign="bottom">
        <a href="http://www.chfpatients.com/contact.htm">
         <span __boilernet_label="0" __num="355">
          Talk to Jon
         </span>
        </a>
       </td>
       <td align="center" class="counter" valign="bottom">
        <a href="http://www.chfpatients.com/index.html">
         <span __boilernet_label="0" __num="356">
          Site Index
         </span>
        </a>
       </td>
      </tr>
     </tbody>
    </table>
   </div>
   <br/>
   <br/>
  </text>
 </body>
</html>